BCL10 mutation does not represent an important pathogenic mechanism in gastric MALT-type lymphoma, and the presence of the API2-MLT fusion is associated with aberrant nuclear BCL10 expression
- 15 February 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (4) , 1398-1404
- https://doi.org/10.1182/blood.v99.4.1398
Abstract
Two recurrent translocations have been associated with mucosa-associated lymphoid tissue (MALT)–type lymphoma, t(11;18)(q21;q21) and t(1;14)(p22;q32). The first, t(11;18)(q21;q21), results in the fusion protein API2-MLT (API2-MALT1). Through t(1;14)(p22;q32), the BCL10 gene is entirely transferred to the IgH gene, resulting in its overexpression. Wild-type BCL10 is implicated in apoptosis, and it has been suggested that mutated forms gain oncogenic activity. The occurrence of genomicBCL10 mutations in 35 gastric MALT-type lymphomas with or without t(11;18)(q21;q21) (10 and 25 cases, respectively) was investigated. DNA extracted from either whole tissue sections or microdissected clusters of tumor cells was used. Five polymerase chain reactions amplifying the coding exons were performed and were followed by direct sequencing of the products. Twenty differences with the published BCL10 sequence, all single nucleotide substitutions, were detected in 16 cases. Of these, 12 represented known polymorphisms, either at codon 8, 213, or 5. Of the remaining 8 substitutions, 2 were silent and 6 resulted in amino acid substitutions. Mutation analysis results were correlated with the BCL10 expression pattern. Aberrant nuclear BCL10 expression was detected in 14 cases. No association could be demonstrated between the latter and the presence of BCL10 mutations. In contrast, all 10 cases carrying t(11;18)(q21;q21) showed nuclear expression, whereas this staining pattern was absent in 21 of 25 cases without t(11;18)(q21;q21). These results demonstrate that BCL10mutations are rare in gastric MALT-type lymphoma and are not related to the aberrant nuclear expression of BCL10. In contrast, they indicate that the presence of the API2-MLT fusion protein is associated with aberrant nuclear BCL10 expression.Keywords
This publication has 25 references indexed in Scilit:
- Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primerPublished by Elsevier ,2004
- Lack ofBCL10 mutations in multiple myeloma and plasma cell leukemiaGenes, Chromosomes and Cancer, 2001
- BCL10 Expression in Normal and Neoplastic Lymphoid TissueThe American Journal of Pathology, 2000
- BCL10 gene mutation in lymphomaBlood, 2000
- The Product of the t(11;18), an API2-MLT Fusion, Marks Nearly Half of Gastric MALT Type Lymphomas without Large Cell ProliferationThe American Journal of Pathology, 2000
- Mutations in Bcl10 are very rare in colorectal cancerBritish Journal of Cancer, 1999
- Lack of Bcl10 mutations in testicular germ cell tumours and derived cell linesBritish Journal of Cancer, 1999
- Bcl10 is not a target for frequent mutation in human carcinomasBritish Journal of Cancer, 1999
- Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32)Nature Genetics, 1999
- Optimizing DOP-PCR for universal amplification of small DNA samples in comparative genomic hybridizationGenes, Chromosomes and Cancer, 1997